OraSure Technologies Acquires CoreBiome and Novosanis
January 4, 2019
OraSure Technologies agreed to acquire two companies—CoreBiome, a Minnesota-based microbiome services provider, and Novosanis, a Belgian urine-collection device maker—to expand its Molecular business. The deals (upfront plus potential performance-based payments) will add microbiome sequencing/bioinformatics and urine first-void collection capabilities to OraSure's specimen collection and molecular diagnostics portfolio.
- Buyers
- OraSure Technologies, Inc.
- Targets
- CoreBiome, Novosanis
- Industry
- Medical Devices
- Location
- Pennsylvania, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Bruker Corporation Acquires biocrates life sciences ag
June 3, 2025
Biotechnology
Bruker Corporation has acquired biocrates life sciences ag, an Innsbruck, Austria-based leader in mass-spectrometry-based quantitative metabolomics. The deal adds biocrates' metabolomics kits, assays, software and contract research services to Bruker's multiomics strategy, expanding Bruker's MS-based metabolomics and integrated multiomics capabilities. Financial terms were not disclosed.
-
Premier Biotech (ACP) Acquires OraSure Toxicology Line and Green Earth Biomedical's Mexican Subsidiary (GEM)
April 10, 2025
Medical Devices
Premier Biotech, a portfolio company of Align Capital Partners, acquired certain assets comprising OraSure Technologies' substance abuse testing business line and the Mexican subsidiary of Green Earth Biomedical LLC (GEM). The transactions expand Premier's oral-fluid toxicology product portfolio and accelerate its international distribution footprint in Mexico and Latin America.
-
OmniActive Health Technologies Acquires ENovate Biolife
November 4, 2024
Food & Beverage
OmniActive Health Technologies has acquired ENovate Biolife to expand its portfolio of clinically validated botanical and specialty active ingredients for dietary supplements, functional foods and sports nutrition. The acquisition strengthens OmniActive's R&D, clinical and commercial capabilities and aims to accelerate global distribution of ENovate's ingredients such as Muvz, RedNite and Oxyjun.
-
Bionano Genomics Acquires BioDiscovery
October 12, 2021
Software
Bionano Genomics agreed to acquire BioDiscovery, a provider of NxClinical genomics analysis software, in a deal worth up to $100 million in cash and equity. The acquisition will integrate BioDiscovery's platform-agnostic analysis and reporting tools with Bionano's optical genome mapping technology to accelerate variant analysis and broaden Bionano's market reach; BioDiscovery founder Soheil Shams will join Bionano as Chief Informatics Officer.
-
OraSure Technologies Acquires UrSure
May 29, 2020
Medical Devices
OraSure Technologies, Inc. has agreed to acquire UrSure, Inc., a Boston-based developer of tests that measure adherence to HIV medications including PrEP, for $3 million upfront plus up to $28 million in contingent consideration. The acquisition expands OraSure's point-of-care and infectious disease diagnostic offerings and strengthens its position in the HIV market by adding adherence-monitoring products and related laboratory capabilities.
-
Canopy Biosciences Acquires Core Diagnostics
December 4, 2019
Biotechnology
Canopy Biosciences, a St. Louis-based multi-omic services company backed by Ampersand Capital Partners, has acquired Core Diagnostics, a California CLIA-certified biomarker analysis laboratory. The acquisition gives Canopy CLIA-certified laboratory capabilities to offer its multi-omic immune profiling services to clinical as well as preclinical and translational customers.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.